UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Journal of clinical oncology, 2017-10, Vol.35 (30), p.3484-3515

2017

Volltextzugriff (PDF)

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Journal of clinical oncology, 2015-10, Vol.33 (30), p.3488-3515

2015

Volltextzugriff (PDF)

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Journal of clinical oncology, 2020-05, Vol.38 (14), p.1608-1632

2020

Volltextzugriff (PDF)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events

Journal for immunotherapy of cancer, 2021-06, Vol.9 (6), p.e002435

2021

Volltextzugriff (PDF)

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2020-03, Vol.38 (7), p.706-714

2020

Volltextzugriff (PDF)

Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3320-3326

2013

Volltextzugriff (PDF)

Fatty acid transport protein 2 reprograms neutrophils in cancer

Nature (London), 2019-05, Vol.569 (7754), p.73-78

2019

Volltextzugriff (PDF)

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline

Journal of clinical oncology, 2022-10, Vol.40 (28), p.3323-3343

2022

Volltextzugriff (PDF)

CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation

Immunity (Cambridge, Mass.), 2016-02, Vol.44 (2), p.303-315

2016

Volltextzugriff (PDF)

Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance)

Journal of clinical oncology, 2015-05, Vol.33 (15), p.1660-1665

2015

Volltextzugriff (PDF)

Precision Medicine in Lung Cancer Treatment

Surgical oncology clinics of North America, 2020-01, Vol.29 (1), p.15-21

2020

Volltextzugriff (PDF)

Safety and Immunogenicity of the PRAME Cancer Immunotherapeutic in Patients with Resected Non–Small Cell Lung Cancer: A Phase I Dose Escalation Study

Journal of thoracic oncology, 2016-12, Vol.11 (12), p.2208-2217

2016

Volltextzugriff (PDF)

Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway

Nature communications, 2021-03, Vol.12 (1), p.1717-1717, Article 1717

2021

Volltextzugriff (PDF)

Linking climate change and species invasion: an illustration using insect herbivores

Global change biology, 2007-08, Vol.13 (8), p.1605-1615

2007

Volltextzugriff (PDF)

Distinct Populations of Immune-Suppressive Macrophages Differentiate from Monocytic Myeloid-Derived Suppressor Cells in Cancer

Cell reports (Cambridge), 2020-12, Vol.33 (13), p.108571-108571, Article 108571

2020

Volltextzugriff (PDF)

Short Communication: Interim toxicity analysis for patients with limited stage small cell lung cancer (LSCLC) treated on CALGB 30610 (Alliance) / RTOG 0538

Lung cancer (Amsterdam, Netherlands), 2021-06, Vol.156, p.68-71

2021

Volltextzugriff (PDF)

Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs

The Journal of experimental medicine, 2019-09, Vol.216 (9), p.2150-2169

2019

Volltextzugriff (PDF)

American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2009-12, Vol.27 (36), p.6251-6266

2009

Volltextzugriff (PDF)

Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology

Journal of clinical oncology, 2015-03, Vol.33 (7), p.786-809

2015

Volltextzugriff (PDF)

Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I-inhibiting Antibody-Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab Govitecan

Clinical cancer research, 2017-10, Vol.23 (19), p.5711-5719

2017

Volltextzugriff (PDF)

Attention to diet, exercise, and weight in oncology care: Results of an American Society of Clinical Oncology national patient survey

Cancer, 2022-07, Vol.128 (14), p.2817-2825

2022

Volltextzugriff (PDF)

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-10, Vol.29 (28), p.3825-3831

2011

Volltextzugriff (PDF)

Randomized Phase II Study of Carboplatin and Etoposide With or Without the bcl-2 Antisense Oligonucleotide Oblimersen for Extensive-Stage Small-Cell Lung Cancer: CALGB 30103

Journal of clinical oncology, 2008-02, Vol.26 (6), p.870-876

2008

Volltextzugriff (PDF)

1 – 25 von 320

Suche als RSS-Feed

Aktive Filter

KollektionOxford University Press Journals Current

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(271)
Mit Volltextzugriff
(250)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(168)
Life Sciences & Biomedicine
(155)
Humans
(123)
Oncology
(74)
Female
(63)
Male
(60)
Middle Aged
(49)
Aged
(47)
Adult
(44)
Biological And Medical Sciences
(39)
Lung Neoplasms - Drug Therapy
(39)
Lung Neoplasms - Pathology
(34)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(29)
Aged, 80 And Over
(28)
Carcinoma, Non-Small-Cell Lung - Pathology
(25)
Medical Sciences
(24)
Neoplasm Staging
(24)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(23)
Neurosciences & Neurology
(21)
Treatment Outcome
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer

Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study

Fatty acid transport protein 2 reprograms neutrophils in cancer

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline

CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation

Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance)

Precision Medicine in Lung Cancer Treatment

Safety and Immunogenicity of the PRAME Cancer Immunotherapeutic in Patients with Resected Non–Small Cell Lung Cancer: A Phase I Dose Escalation Study

Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway

Linking climate change and species invasion: an illustration using insect herbivores

Distinct Populations of Immune-Suppressive Macrophages Differentiate from Monocytic Myeloid-Derived Suppressor Cells in Cancer

Short Communication: Interim toxicity analysis for patients with limited stage small cell lung cancer (LSCLC) treated on CALGB 30610 (Alliance) / RTOG 0538

Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs

American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology

Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I-inhibiting Antibody-Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab Govitecan

Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients

Attention to diet, exercise, and weight in oncology care: Results of an American Society of Clinical Oncology national patient survey

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Randomized Phase II Study of Carboplatin and Etoposide With or Without the bcl-2 Antisense Oligonucleotide Oblimersen for Extensive-Stage Small-Cell Lung Cancer: CALGB 30103

Aktive Filter

Suchergebnisse filtern